Nabiximols, an oromucosal spray of an entire cannabis plant extract by using a one:one ratio of THC to cannabidiol (CBD), was in the beginning certified and permitted in Europe, the United Kingdom, and Canada to the procedure of discomfort and spasticity associated with numerous sclerosis (GW Pharmaceuticals, 2016; Pertwee, 2012), but it carries on